Welcome to our dedicated page for Tema Healthcare AI ETF news (Ticker: HLTH), a resource for investors and traders seeking the latest updates and insights on Tema Healthcare AI ETF stock.
Cue Health Inc. news covered the company's healthcare technology business, including diagnostic-enabled care, at-home and point-of-care molecular testing, telehealth services, FDA-related product developments, earnings releases, and governance actions. Recurring updates described its COVID-19 and Mpox diagnostic products, customer categories across public agencies and private-sector healthcare users, and cost-reduction or operational efficiency actions.
Later Cue Health news documented the company's Chapter 7 bankruptcy filing and planned wind down, including the intended sale of assets and creditor-payment process under the Bankruptcy Code.
Cue Health has priced its initial public offering (IPO) at $16.00 per share, totaling $200 million in gross proceeds. A total of 12,500,000 shares will be offered, expected to begin trading on Nasdaq under the ticker HLTH on September 24, 2021. The offering is set to close on September 28, 2021, pending customary conditions. Additionally, underwriters have a 30-day option to buy 1,875,000 more shares at the IPO price. Goldman Sachs, Morgan Stanley, and Cowen are leading the offering.
Cue Health has filed a registration statement on Form S-1 with the SEC for a proposed initial public offering (IPO) of its common stock, with details on the number of shares and price range yet to be determined. The company plans to list its stock on the Nasdaq under the ticker symbol HLTH. Goldman Sachs, Morgan Stanley, and Cowen will act as lead underwriters for the offering. A preliminary prospectus will be available once the statement becomes effective.